Peptide T is primarily studied for its potential therapeutic applications, particularly in the field of neurology and immunology. It has been investigated for its ability to modulate the immune system and its potential role in treating conditions such as HIV/AIDS. Research suggests that it may help in reducing neuroinflammation and improving cognitive function in patients with HIV-associated neurocognitive disorders. Additionally, Peptide T is explored for its potential to alleviate symptoms of chronic fatigue syndrome and fibromyalgia due to its interaction with the immune system and its anti-inflammatory properties. Its ability to bind to specific receptors in the brain also makes it a candidate for further research in treating other neurological and inflammatory conditions.